Differential impact of prognostic parameters in hormone receptor-positive lobular breast cancer.
Matthias ChristgenOleg GluzNadia HarbeckRonald E KatesMieke RaapHenriette ChristgenMichael ClemensWolfram MalterBenno NudingBahriye AktasSherko KuemmelToralf ReimerAndrea StefekPetra KrabischMarianne JustDoris AugustinMonika GraeserFrederick L BaehnerRachel WuerstleinUlrike NitzHans Kreipenull nullPublished in: Cancer (2020)
Lobular BC is associated with low and intermediate RS, although 5-year DFS is similar to that of nonlobular BC. The effect of the RS in lobular BC appears to be distinct from that in nonlobular BC. For risk assessment, the RS needs to be complemented by clinicopathologic parameters for therapy decision making.